 |
인쇄하기
취소
|
Celltrion chairman’s sell-out plan boosts stock price
Celltrion chairman Seo Jung-jin announces Tuesday his plan to sell all of his stakes in the Kosdaq’s No. 1 market cap company and its affiliates to a multinational pharmaceutical company, citing predatory short-selling as the main reason behind the move.
Shares of Celltrion jumped 5 percent on the recent news, closing at 49,800 won.
A short-selling refers to the practice that sees investo...
Shares of Celltrion jumped 5 percent on the recent news, closing at 49,800 won.
A short-selling refers to the practice that sees investo...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.